Effects of ketoconazole in hirsute women.

  title={Effects of ketoconazole in hirsute women.},
  author={Sema Akalın},
  journal={Acta endocrinologica},
  volume={124 1},
  • S. Akalın
  • Published 1991
  • Medicine, Biology
  • Acta endocrinologica
To determine the efficacy of ketoconazole in the treatment of hirsutism, clinical and hormonal effects of this agent were evaluated with a randomized, placebo-controlled, double-blind cross-over study design. Nine hirsute women were given ketoconazole (600 mg/day) or placebo for 6 months and then crossed over. The severity of hirsutism was assessed according to the scale of Ferriman & Gallwey. Baseline serum testosterone, dehydroepiandrosterone sulphate, progesterone, estradiol, basal and… 

Tables from this paper

Ketoconazole therapy: hormonal and clinical effects in non-tumoral hyperandrogenism.
After 9 months of ketoconazole treatment, the patients' Ferriman & Gallway scores improved markedly and acne had improved markedly, and Hormone patterns also became more favorable, with decreases in androgenic steroids and increases in estradiol.
Low Dose Ketoconazole is an Effective and a Relatively Safe Alternative in the Treatment of Hirsutism*
Low dose ketoconazole seems to be effective in the treatment of hirsutism with relatively few side‐effects but still should be reserved as an alternative choice due to the potential for deleterious hepatic effects.
Finasteride cream in hirsutism.
  • K. J. Lucas
  • Medicine
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • 2001
Topically applied finasteride significantly decreased hair growth and thickness, and no adverse effects were noted in this study of women with facial hirsutism.
Topical Finasteride in Hirsutism: A Double Blind Randomized Clinical Trial on Adult Women
Six months of topically applied finasteride (0.5%) does not affect on number and thickness of facial hirsutism significantly and despite lack of objective changes, most patients in finastride group perceived a decrease in hair growth with time.
Preparation and clinical evaluation of Finastride gel in the treatment of idiopathic Hirsutism
Because of the good absorption through the skin and good solubility of this medicine, the prepared gel formulation applied on the hirsutism area showed a significant decrease in hair growth locally, so finasteride gel is an efficient and harmless therapy in patients with idiopathic hirutism.
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
There was low quality evidence for the effect of two oral contraceptive pills (OCPs) and change in androgen levels were addressed in most comparisons, change in body mass index (BMI) and improvement of other clinical signs of hyperandrogenism in one-third of studies.
The treatment of women with hirsutism
If elevation of baseline follicular phase 17-OH progesterone is accepted as the criterion for diagnosis, nonclassical congenital adrenal hyperplasia accounts for between 0 and 6% of women referred to hospital with hirsutism.
Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome
It is suggested that endogenous androgens, no matter whether they are of ovarian or adrenal origin, do not play a major role in the modulation of hyperinsulinemia in patients with polycystic ovary syndrome.
Treatment of androgen excess in females: yesterday, today and tomorrow.
  • E. Pucci, F. Petraglia
  • Medicine, Biology
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 1997
An appraisal of what is presently known about the regulation of hair growth, the various causes of excessive androgen secretion and the current methods to solve, safely, this important feminine clinical problem is provided.
Other Antiandrogens
The question is raised whether the term ‘antiandrogen’ should be amplified by including the 5α-reductase inhibitors, which would pay tribute to the biological aspect of antiandrogenicity that takes into account not only the mode of action but also the effects of the substance.


Ketoconazole in the treatment of acne in women.
Ketoconazole, an oral imidazole antifungal drug, is a potent inhibitor of testosterone synthesis that has been recently used to induce and maintain a remission in patients with advanced prostatic cancer.
Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy.
Administration of ketoconazole may be a satisfactory treatment for precocious puberty in boys and possibly for other conditions characterized by androgen excess, preliminary data suggest.
Prolonged treatment of Cushing's disease by ketoconazole.
Findings indicate that ketoconazole may be a valuable drug for the management of patients with Cushing's disease because of its ability to correct hypercortisolism quickly.
Reversible adrenal insufficiency induced by ketoconazole.
A patient who developed symptoms and signs of hypoadrenalism while receiving an experimentally high daily dose of ketoconazole was reported, and the results of serum and urinary steroid measurements confirmed this clinical impression.
Ketoconazole-induced increase in estradiol-testosterone ratio. Probable explanation for gynecomastia.
The selective hormonal effect demonstrated may explain the side effect of gynecomastia after ketoconazole therapy, which appears to be the result of an elevated estradiol-testosterone ratio.
Site of action of low dose ketoconazole on androgen biosynthesis in men.
Ketoconazole represents another compound with relatively selective effects on a cytochrome P-450-mediated steroid hydroxylation step, namely that involved with C17-20 lyase, and was supported by the highly significant increase in the ratio of plasma 17 alpha-hydroxyprogesterone to androstenedione observed between 2 and 24 h after drug administration.
Ketoconazole blocks adrenal steroid synthesis.
In healthy humans, the cortisol response to adrenocorticotropic hormone was significantly blunted 4 hours after a 400-mg or 600-mg dose, and this finding indicated that adrenal androgen response was reduced.
Constancy of opioid control of luteinizing hormone in different pathophysiological states.
It is concluded that LH is under inhibitory opioid control both in normal subjects and in widely differing pathological states of the gonadotropic axis.
Clinical assessment of body hair growth in women.
A method was developed for the semiquantitative assessment of body hair growth, and suitable for use in the study of clinical problems associated with hirsuties in women, and an “hormonal” score obtained by adding the gradings obtained from 9 of the 11 sites is being employed in clinical studies.
Clinical review 10: An endocrinologic approach to the patient with hirsutism.
This review will focus on current concepts of the role of androgens in the pathogenesis of hirsutism, the etiology of androgen excess, the use of GnRH agonists as both diagnostic and therapeutic